Charl van Zyl
Chief Executive Officer chez H. LUNDBECK A/S
Profil
Charl van Zyl is currently the President & Chief Executive Officer at H.
Lundbeck A.
He is also a Director at the Biotechnology Innovation Organization, Ra Pharmaceuticals, Inc., UCB Celltech, and UCB SA. In the past, Mr. van Zyl served as the Chief Executive Officer at JADO Technologies GmbH from 2007 to 2009.
He was also the Executive Vice President at Bausch & Lomb, Inc. from 2009 to 2013.
Additionally, he worked as a Marketing Manager at Eli Lilly & Co. from 1995 to 2004.
Mr. van Zyl held the position of Head-Sales & Marketing at Novartis AG from 2004 to 2007, and as the Executive Vice President at BSN Medical SA from 2014 to 2017.
Mr. van Zyl completed his undergraduate degree at the University of Cape Town in 1991.
Postes actifs de Charl van Zyl
Sociétés | Poste | Début |
---|---|---|
UCB | Corporate Officer/Principal | 01/02/2020 |
RA PHARMACEUTICALS, INC. | Director/Board Member | 02/04/2020 |
H. LUNDBECK A/S | Chief Executive Officer | 01/10/2023 |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The private company is based in Slough, UK and was founded in 2006. | Director/Board Member | 10/05/2017 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Anciens postes connus de Charl van Zyl
Sociétés | Poste | Fin |
---|---|---|
BSN Medical SA
BSN Medical SA Pharmaceuticals: MajorHealth Technology BSN medical is a multinational company and one of the world leaders in producing and distributing medical products in the segments of plaster, bandages, wound care and compression therapy. Some of its brands are well known - Gypsona ®, Delta-Cast ®, Jobst ® and Tricodur ® - these are vetrouwde names in the medical industry. They have production sites in France, Germany, Mexico, Pakistan, South Africa, United Kingdom and the United States. Sales and marketing its products in major markets by BSN Medical themselves represented as a separate entity. BSN Medical employs approximately 3400 people and has a global turnover of more than 605 million Euros in 2009. BSN medical in April 2001 emerged from a 50:50 joint venture between the companies Beiersdorf AG, Hamburg, and Smith & Nephew plc, London. Purpose of this joint venture was the grouping of geographic and channel strengths in wound care, fracture treatment, physiotherapy and phebologie. | Corporate Officer/Principal | 01/01/2017 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Corporate Officer/Principal | 01/01/2013 |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | Chief Executive Officer | 01/01/2009 |
NOVARTIS AG | Sales & Marketing | 01/01/2007 |
░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Charl van Zyl
University of Cape Town | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
H. LUNDBECK A/S | Health Technology |
NOVARTIS AG | Health Technology |
UCB | Health Technology |
Entreprise privées | 7 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Bausch & Lomb Holdings, Inc.
Bausch & Lomb Holdings, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb Holdings, Inc. developed, manufactured, and sold eye health products. Its products included contact lenses, contact lens care solutions, ophthalmic pharmaceuticals, and surgical products. The company was founded on September 25, 2009 and was headquartered in Rochester, NY. | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | Retail Trade |
BSN Medical SA
BSN Medical SA Pharmaceuticals: MajorHealth Technology BSN medical is a multinational company and one of the world leaders in producing and distributing medical products in the segments of plaster, bandages, wound care and compression therapy. Some of its brands are well known - Gypsona ®, Delta-Cast ®, Jobst ® and Tricodur ® - these are vetrouwde names in the medical industry. They have production sites in France, Germany, Mexico, Pakistan, South Africa, United Kingdom and the United States. Sales and marketing its products in major markets by BSN Medical themselves represented as a separate entity. BSN Medical employs approximately 3400 people and has a global turnover of more than 605 million Euros in 2009. BSN medical in April 2001 emerged from a 50:50 joint venture between the companies Beiersdorf AG, Hamburg, and Smith & Nephew plc, London. Purpose of this joint venture was the grouping of geographic and channel strengths in wound care, fracture treatment, physiotherapy and phebologie. | Health Technology |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The private company is based in Slough, UK and was founded in 2006. | Health Technology |